Tuhura Biosciences Stock Z Score
| HURA Stock | 4.48 0.48 12.00% |
TuHURA | Z Score |
TuHURA Biosciences Company Z Score Analysis
TuHURA Biosciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
TuHURA Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for TuHURA Biosciences is extremely important. It helps to project a fair market value of TuHURA Stock properly, considering its historical fundamentals such as Z Score. Since TuHURA Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TuHURA Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TuHURA Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
According to the company's disclosures, TuHURA Biosciences has a Z Score of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The z score for all United States stocks is 100.0% higher than that of the company.
TuHURA Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of TuHURA Biosciences from analyzing TuHURA Biosciences' financial statements. These drivers represent accounts that assess TuHURA Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of TuHURA Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 498.7M | 115.3M | 2.1B | 390.7M | 351.6M | 587.5M | |
| Enterprise Value | 492.7M | 111.6M | 2.0B | 376.5M | 338.9M | 321.9M |
TuHURA Fundamentals
| Current Valuation | 193.58 M | ||||
| Shares Outstanding | 26 M | ||||
| Number Of Shares Shorted | 391.32 K | ||||
| Price To Book | 133.78 X | ||||
| EBITDA | (29.12 M) | ||||
| Net Income | (29.32 M) | ||||
| Total Debt | 2.34 M | ||||
| Cash Flow From Operations | (7.18 M) | ||||
| Target Price | 15.0 | ||||
| Market Capitalization | 141.65 M | ||||
| Total Asset | 4.36 M | ||||
| Retained Earnings | (88.47 M) | ||||
| Working Capital | 562.42 K | ||||
| Net Asset | 4.36 M |
About TuHURA Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TuHURA Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TuHURA Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TuHURA Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:Check out TuHURA Biosciences Piotroski F Score and TuHURA Biosciences Valuation analysis. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.